SCHEMBL2954629

SCHEMBL2954629

CN(C)c1ccc(-c2nc3c(C(=O)O)cccc3o2)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TOP2A P11388 2/20 0.53
MAPT P10636 3/20 0.50
RXFP1 Q9HBX9 2/20 0.50
PTPRF P10586 1/20 0.46
PTPN2 P17706 1/20 0.46
PTPN1 P18031 1/20 0.46
NPC1 O15118 2/20 0.45
RAB9A P51151 2/20 0.45
MEN1 O00255 2/20 0.45
KMT2A Q03164 2/20 0.45
CASP3 P42574 1/20 0.45
HTR3A P46098 4/20 0.44
DHODH Q02127 1/20 0.44
PARP1 P09874 1/20 0.43
SLC16A3 O15427 1/20 0.43
APP P05067 1/20 0.42
DDX3X O00571 1/20 0.42
IDO1 P14902 1/20 0.42
MAOA P21397 1/20 0.42
MAOB P27338 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28926584 0.89 TOP2A (0.59) TOP2AMAPTNPC1RAB9AMEN1
SCHEMBL206232 0.85 TOP2A (0.56) TOP2AMAPTPTPRFPTPN2PTPN1
SCHEMBL121325 0.84 TOP2A (0.65) TOP2AMAPTNPC1RAB9AMEN1
SCHEMBL16383496 0.83 TOP2A (0.54) TOP2AMAPTPTPN1NPC1RAB9A
SCHEMBL205351 0.82 TOP2A (0.53) TOP2AMAPTRXFP1NPC1RAB9A
SCHEMBL120321 0.82 HTR3A (0.54) TOP2AMAPTPTPN2PTPN1CASP3
SCHEMBL121392 0.82 HTR3A (0.54) TOP2AMAPTPTPN2PTPN1NPC1
SCHEMBL2957072 0.81 TOP2A (0.59) TOP2AMAPTRXFP1PTPN2PTPN1
SCHEMBL2961027 0.80 TOP2A (0.54) TOP2AMAPTRXFP1NPC1RAB9A
SCHEMBL27937347 0.79 NPC1 (0.48) MAPTRXFP1PTPN1NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7781430-B2 Benzoxazole carboxamides for treating CINV and IBS-D ALBANY MOLECULAR RESEARCH, INC. (US) 2010-08-24 US disclosed
US-20080108609-A1 Benzoxazole Carboxamides For Treating CINV and IBS-D AMR TECHNOLOGY, INC. (US) 2008-05-08 US disclosed
CN-101160307-A Benzoxazole carboxamides for the treatment of CINV and IBS-D AMR TECHNOLOGY INC (US) 2008-04-09 CN disclosed
US-7307094-B2 Benzoxazole carboxamides for treating CINV and IBS-D AMR TECHNOLOGY, INC. (US) 2007-12-11 US disclosed
EP-1853597-A1 BENZOXAZOLE CARBOXAMIDES FOR TREATING CINV AND IBS-D AMR Technology, Inc. (US) 2007-11-14 EP disclosed
WO-2006089100-A1 BENZOXAZOLE CARBOXAMIDES FOR TREATING CINV AND IBS-D AMR TECHNOLOGY, INC. (US) 2006-08-24 WO disclosed
US-20060183769-A1 Benzoxazole carboxamides for treating CINV and IBS-D AMR TECHNOLOGY, INC. (US) 2006-08-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080108609-A1 Benzoxazole Carboxamides For Treating CINV and IBS-D HTR3E, BRS3, HTR3A TOP2A 1421/4885MAPT 4376/4885RXFP1 371/4885
US-20060183769-A1 Benzoxazole carboxamides for treating CINV and IBS-D HTR3E, BRS3, HTR3A TOP2A 1421/4885MAPT 4376/4885RXFP1 371/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.